Related Experiment Video
Updated: Feb 22, 2026

Identification of Nucleolar Factors During HIV-1 Replication Through Rev Immunoprecipitation and Mass Spectrometry
Published on: June 26, 2019
Human SLC26A4/Pendrin STAS domain is a nucleotide-binding protein: Refolding and characterization for structural
Alok K Sharma1, Tobias Krieger1,2, Alan C Rigby3
1Division of Nephrology and Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Department of Medicine, Harvard Medical School, Boston, MA 02215, United States.
Mutations in the human Pendrin STAS domain (hPDS STAS-ΔIVS) are linked to Pendred Syndrome. This study details its protein refolding and characterization, revealing GDP binding crucial for understanding congenital deafness.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- Mutations in the human SLC26A4/Pendrin polypeptide (hPDS) are associated with Pendred Syndrome and DFNB4, characterized by hearing loss and vestibular aqueduct enlargement.
- The STAS (Sulfate Transporter Anion Transporter Sigma) domain is a key cytoplasmic subdomain of pendrin, implicated in its function and associated genetic disorders.
Purpose of the Study:
- To clone, overexpress, purify, and biophysically characterize the recombinant hPDS STAS domain lacking its intrinsic variable sequence (STAS-ΔIVS).
- To establish a reproducible protein refolding protocol for milligram-scale expression and purification of uniformly enriched hPDS STAS-ΔIVS for structural studies.
- To investigate the interaction of hPDS STAS-ΔIVS with GDP using biophysical and NMR techniques.
Main Methods:
- Recombinant protein expression, purification, and refolding of the hPDS STAS-ΔIVS domain.
- Circular dichroism (CD) spectroscopy for secondary structure assessment.
- Nuclear Magnetic Resonance (NMR) spectroscopy (1D 1H, 2D 1H-15N HSQC, 2D 1H-13C HSQC) for structural integrity and interaction studies.
- Heteronuclear NMR chemical shift perturbation (CSP) experiments to map GDP binding sites.
- Intrinsic tryptophan fluorescence quench experiments to determine binding affinity (Kd).
Main Results:
- A reproducible protocol was developed for milligram-scale expression and purification of refolded hPDS STAS-ΔIVS.
- CD and NMR spectra confirmed the well-folded state of the purified protein in solution.
- NMR CSP experiments indicated GDP binding to specific residues of hPDS STAS-ΔIVS.
- Fluorescence spectroscopy revealed GDP binding with a Kd of 178 μM.
Conclusions:
- The study successfully produced and characterized the recombinant hPDS STAS-ΔIVS domain, suitable for structural analysis.
- GDP binding to the hPDS STAS-ΔIVS domain was demonstrated, providing insights into its functional mechanism.
- These findings contribute to the structure-function understanding of pendrin and other mammalian STAS domains, relevant for congenital deafness research.
Related Concept Videos
Conservation of Protein Domains Over Different Proteins
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Molecular Chaperones and Protein Folding
The...
Directing Proteins to the Rough Endoplasmic Reticulum

